CYP19A1 and breast cancer: Noteworthy, however, studies have shown robust expression of aromatase not only in various BC subtypes, but also in non-cancerous breast epithelial cells [21,22,23], warranting improved understanding for diagnosis and therapy for this aggressive disease.